Amphiregulin As A Monitoring Biomarker During Treatment Of Acute Gvhd

Amphiregulin as a monitoring biomarker during treatment of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarker testing may transform treatment of acute GVHD (Part 1)

MDedge: news and insights for busy physicians

Biomarker testing may transform treatment of acute GVHD (Part 2)

MDedge: news and insights for busy physicians

Overcoming the Challenges of Acute and Chronic GVHD

PeerView Oncology

Key biomarkers in the management of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

What is the latest update on biomarkers for assessing GvHD?

Biomarkers for Graft-Versus-Host Disease: What Is a Biomarker?

Managed Healthcare Executive

Repurposing drugs for the treatment of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

How Biomarkers Revolutionize Disease Diagnosis, Treatment, and Monitoring

Biomarkers for Graft-Versus-Host Disease: Biomarkers as Companion Diagnostics

Managed Healthcare Executive

How I treat GVHD: Dr. James Ferrara explains how biomarkers can predict outcomes

MDedge: news and insights for busy physicians

Advances and unmet needs in chronic GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarkers for Graft-Versus-Host Disease: Biomarkers and Alternatives to Corticosteroid Treatment

Managed Healthcare Executive

GvHD highlights: use of biomarkers to guide treatment

VJHemOnc – Video Journal of Hematology & HemOnc

First pediatric drug approval for prevention of graft-versus-host disease

Dana-Farber Cancer Institute

Clinical Perspective: Integrating Ruxolitinib into the Treatment of Acute GVHD

Pooled allogenic FMT for the treatment of steroid-refractory intestinal acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Methods for Assessing Acute GVHD

Targeted Oncology

How would you treat aGvHD in your clinic (an EU perspective)?

REG3α as a biomarker and therapeutic target for GVHD

Journal of Clinical Investigation